Infection-Related Safety Profile of Rifaximin Repeat Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

The American Journal of Gastroenterology ◽

10.14309/00000434-201510001-01766 ◽

2015 ◽

Vol 110 ◽

pp. S750-S751

Author(s):

William D. Chey ◽

Anthony J. Lembo ◽

Ray A. Wolf

Keyword(s):

Irritable Bowel Syndrome ◽

Safety Profile ◽

Repeat Treatment ◽

Irritable Bowel

Download Full-text

Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial

Therapeutic Advances in Gastroenterology ◽

10.1177/1756283x17726087 ◽

2017 ◽

Vol 10 (9) ◽

pp. 689-699 ◽

Author(s):

Brooks D. Cash ◽

Mark Pimentel ◽

Satish S. C. Rao ◽

Leonard Weinstock ◽

Lin Chang ◽

...

Keyword(s):

Quality Of Life ◽

Irritable Bowel Syndrome ◽

Controlled Trial ◽

Secondary Analysis ◽

Double Blind ◽

Double Blind Placebo ◽

Repeat Treatment ◽

Related Quality ◽

Irritable Bowel

Download Full-text

458 - Lack of Development of Opportunistic Infections, Including Candidiasis, in Patients with Diarrhea-Predominant Irritable Bowel Syndrome Receiving Repeat Treatment with Rifaximin

Gastroenterology ◽

10.1016/s0016-5085(18)30792-3 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-106

Author(s):

Mark Pimentel ◽

Anthony J. Lembo ◽

Zeev Heimanson ◽

Brian E. Lacy

Keyword(s):

Irritable Bowel Syndrome ◽

Opportunistic Infections ◽

Repeat Treatment ◽

Irritable Bowel

Download Full-text

Rifaximin Repeat Treatment in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Produced No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity

The American Journal of Gastroenterology ◽

10.14309/00000434-201510001-01790 ◽

2015 ◽

Vol 110 ◽

pp. S761 ◽

Author(s):

Mark Pimentel ◽

Lin Chang ◽

Anthony J. Lembo ◽

Ray A. Wolf

Keyword(s):

Irritable Bowel Syndrome ◽

Antibiotic Sensitivity ◽

Repeat Treatment ◽

Clinically Significant ◽

Irritable Bowel

Download Full-text

Improvements over Time in Individual Diarrhea-Predominant Irritable Bowel Syndrome Symptoms (IBS-D) with Rifaximin Repeat Treatment

The American Journal of Gastroenterology ◽

10.14309/00000434-201610001-00530 ◽

2016 ◽

Vol 111 ◽

pp. S240

Author(s):

Mark Pimentel ◽

Anthony J. Lembo ◽

Ray Wolf

Keyword(s):

Irritable Bowel Syndrome ◽

Repeat Treatment ◽

Irritable Bowel ◽

Download Full-text

The Cardiovascular Safety Profile of Renzapride, a Novel Treatment for Irritable Bowel Syndrome

Journal of International Medical Research ◽

10.1177/147323000703500613 ◽

2007 ◽

Vol 35 (6) ◽

pp. 848-866 ◽

Author(s):

NL Meyers ◽

RI Hickling

Keyword(s):

Irritable Bowel Syndrome ◽

Safety Profile ◽

Cardiovascular Safety ◽

Novel Treatment ◽

Irritable Bowel

Download Full-text

Su1190 - Characterization of Long-Term Rifaximin Responders from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Repeat Treatment Trial for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Gastroenterology ◽

10.1016/s0016-5085(18)31890-0 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-498

Author(s):

Leonard Weinstock ◽

Mark Pimentel ◽

Zeev Heimanson ◽

Anthony J. Lembo

Keyword(s):

Irritable Bowel Syndrome ◽

Treatment Trial ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Repeat Treatment ◽

Irritable Bowel

Download Full-text

S0495 The Safety Profile of Tegaserod 6 Mg BID in Irritable Bowel Syndrome With Constipation in Women <65 Years of Age Without Cardiovascular Disease History

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000704028.06576.5a ◽

2020 ◽

Vol 115 (1) ◽

pp. S247-S247

Author(s):

Eric D. Shah ◽

Brian E. Lacy ◽

William D. Chey ◽

Lin Chang ◽

Darren M. Brenner

Keyword(s):

Cardiovascular Disease ◽

Irritable Bowel Syndrome ◽

Safety Profile ◽

Irritable Bowel

Download Full-text

Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

Gastroenterology ◽

10.1053/j.gastro.2016.08.003 ◽

2016 ◽

Vol 151 (6) ◽

pp. 1113-1121 ◽

Author(s):

Anthony Lembo ◽

Mark Pimentel ◽

Satish S. Rao ◽

Philip Schoenfeld ◽

Brooks Cash ◽

...

Keyword(s):

Irritable Bowel Syndrome ◽

Repeat Treatment ◽

Irritable Bowel

Download Full-text

442 – Safety Profile of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea Reporting Inadequate Symptom Control with Prior Loperamide Use: A Phase 4 Study (Relief)

Gastroenterology ◽

10.1016/s0016-5085(19)37015-5 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-91-S-92 ◽

Author(s):

Brooks D. Cash ◽

Darren M. Brenner ◽

Steven Elmes ◽

Gregory S. Sayuk ◽

Louis W. Liu

Keyword(s):

Irritable Bowel Syndrome ◽

Safety Profile ◽

Symptom Control ◽

Irritable Bowel

Download Full-text

Su1195 - Rifaximin Repeat Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Impact on Clostridium Difficile Infection Development

Gastroenterology ◽

10.1016/s0016-5085(18)31895-x ◽

2018 ◽

Vol 154 (6) ◽

pp. S-499-S-500

Author(s):

Mark Pimentel ◽

Phillip Schoenfeld ◽

Zeev Heimanson ◽

Brooks D. Cash

Keyword(s):

Irritable Bowel Syndrome ◽

Clostridium Difficile ◽

Clostridium Difficile Infection ◽

Repeat Treatment ◽

Irritable Bowel

Download Full-text